Olanzapine

This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on July 6, 2024.

Return to the list of Patented Medicine Litigation page.

ZYPREXA, ZYPREXA INTRAMUSCULAR, ZYPREXA ZYDIS – Eli Lilly Canada Inc. (NOC Search)

Patents:

1075687: NOVOPHARM, SUN PHARMA, APOTEX, GENPHARM, MELIAPHARM, COBALT, SANDOZ, TEVA
1750687: APOTEX
2041113: RATIOPHARM, SANIS HEALTH, MELIAPHARM, SUN PHARMA, NOVOPHARM, SUN PHARMA, GENPHARM, PHARMEL, DOMINION, RIVA, PRO DOC, MYLAN, NU-PHARM, APOTEX, PHARMASCIENCE, MELIAPHARM, SIGMACON, COBALT, TEVA, SANDOZ
2214005: GENPHARM, PHARMASCIENCE, MELIAPHARM, SANIS HEALTH, RATIOPHARM, NOVOPHARM, SUN PHARMA, APOTEX, NU-PHARM, SANDOZ, TEVA, COBALT
2216372: GENPHARM, MELIAPHARM, SUN PHARMA, APOTEX, RATIOPHARM, TEVA, COBALT, NU-PHARM
2265712: RATIOPHARM, APOTEX, COBALT

APOTEX

Impeachment – T-1971-07
Infringement – T-1738-11
PM(NOC) – A-261-07 (2008 FCA 44) – A-400-10 (2013 FCA 282) – T-1285-09 – T-1347-09 – T-156-05 (2007 FC 455, 2010 FC 952) – T-479-05 – T-787-05 – T-794-09 (2009 FC 1053)

COBALT

PM(NOC) – T-1731-08 – T-544-09 – T-545-09 – T-73-09
Infringement – T-1554-10

DOMINION

Infringement – T-1555-10

GENPHARM

PM(NOC) – T-1745-08 – T-989-08

MELIAPHARM

PM(NOC) – T-1606-10

MYLAN

Infringement – T-1550-10

NOVOPHARM

PM(NOC) – A-274-07 (2007 FCA 329, 2007 FCA 359) – A-565-08 (2009 FCA 138, 2009 FCA 24) – T-1532-05 (2006 FC 1447, 2007 FC 596, 2007 FC 708) – T-1734-04 – T-2069-04 – T-701-08 – T-703-08 (2008 FC 1221, 2008 FC 875, 2009 FC 675)
Appeal – A-114-08 (2008 FCA 287) – A-454-09 (2010 FCA 130, 2010 FCA 197, 2010 FCA 219) – A-473-11 (2012 FCA 232)

NU-PHARM

PM(NOC) – T-986-08 – T-988-08
Infringement – T-1548-10 (2011 FC 255)

PHARMASCIENCE

PM(NOC) – T-1447-07
Infringement – T-1497-08

PHARMEL

Infringement – T-1549-10

PRO DOC

Infringement – T-1556-10

RATIOPHARM

PM(NOC) – T-1346-09 – T-1367-09

RIVA

Infringement – T-1552-10

SANDOZ

Infringement – T-1553-10
PM(NOC) – T-1389-07 – T-1391-07 – T-147-09 – T-148-09 – T-668-09 – T-669-09

SANIS HEALTH

PM(NOC) – T-1195-10

SANIS HEALTH, MELIAPHARM, SUN PHARMA

PM(NOC) – T-2023-10

SIGMACON

Infringement – T-1551-10

SUN PHARMA

PM(NOC) – T-1973-10 – T-1974-10

TEVA

PM(NOC) – T-398-11
Infringement – T-1048-07 (2007 FC 1126, 2007 FC 1195, 2008 FC 281, 2009 FC 1018, 2010 FC 241, 2011 FC 1288, 2013 FC 677, 2015 FC 801, 2017 FC 88) – T-989-13 (2016 FC 1131)
Appeal – A-71-17 (2018 FCA 53)

Return to the Patented Medicine Litigation page.

Olanzapine

Canadian Intellectual Property